These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14984383)

  • 21. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC
    Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous versus oral omeprazole on patients with high risk bleeding peptic ulcers: A prospective randomized clinical trial protocol.
    Zhang J; Diao P; Zhang L
    Medicine (Baltimore); 2021 Apr; 100(14):e25136. PubMed ID: 33832076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
    Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
    Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.
    Schaffalitzky de Muckadell OB; Havelund T; Harling H; Boesby S; Snel P; Vreeburg EM; Eriksson S; Fernström P; Hasselgren G
    Scand J Gastroenterol; 1997 Apr; 32(4):320-7. PubMed ID: 9140153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.
    Yeomans ND
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):447-55. PubMed ID: 21780891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
    Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
    Chan WH; Khin LW; Chung YF; Goh YC; Ong HS; Wong WK
    Br J Surg; 2011 May; 98(5):640-4. PubMed ID: 21305536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
    Pittayanon R; Piyachaturawat P; Rerknimitr R; Prueksapanich P; Chaitongrat S; Lertsuwunseri V; Srimahachota S; Mahachai V
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1517-1522. PubMed ID: 30919492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aspirin and cardiovascular prevention: last minute information].
    Kulbertus H
    Rev Med Liege; 2005 Mar; 60(3):198-200. PubMed ID: 15884703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
    Chan FKL; Ching JYL; Tse YK; Lam K; Wong GLH; Ng SC; Lee V; Au KWL; Cheong PK; Suen BY; Chan H; Kee KM; Lo A; Wong VWS; Wu JCY; Kyaw MH
    Lancet; 2017 Jun; 389(10087):2375-2382. PubMed ID: 28410791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND
    Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
    J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of omeprazole and placebo for bleeding peptic ulcer.
    Khuroo MS; Yattoo GN; Javid G; Khan BA; Shah AA; Gulzar GM; Sodi JS
    N Engl J Med; 1997 Apr; 336(15):1054-8. PubMed ID: 9091801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding.
    Riemann JF; Schilling D; Schauwecker P; Wehlen G; Dorlars D; Kohler B; Maier M
    Gastrointest Endosc; 1997 Oct; 46(4):299-304. PubMed ID: 9351030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.